D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
PUT
Lear
LEA
$7.19B
| $16.9M | 0.02% |
122,900
+100
| +0.1% | +$12.4K |
|
877
CALL
Accenture
ACN
$89.9B
| $16.8M | 0.02% |
80,000
+28,000
| +54% | +$5.46M |
|
878
PUT
PepsiCo
PEP
$186B
| $16.8M | 0.02% |
122,900
-60,100
| -33% | -$8.18M |
|
879
Teck Resources
TECK
$29.5B
| $16.8M | 0.02% |
968,534
+307,545
| +47% | +$5.02M |
|
880
Bio-Techne
TECH
$11.2B
| $16.8M | 0.02% |
305,776
+6,460
| +2% | +$339K |
|
881
Upbound Group
UPBD
$1.19B
| $16.8M | 0.02% |
581,604
-129,967
| -18% | -$3.4M |
|
882
PUT
Transocean
RIG
$5.92B
| $16.8M | 0.02% |
2,435,600
-1,484,700
| -38% | -$7.65M |
|
883
CALL
Elevance Health
ELV
$81.9B
| $16.7M | 0.02% |
55,300
+12,900
| +30% | +$3.55M |
|
884
Thomson Reuters
TRI
$39.4B
| $16.7M | 0.02% |
221,463
-150,638
| -40% | -$11M |
|
|
EVBG
885
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $16.7M | 0.02% |
213,614
-50,115
| -19% | -$3.87M |
|
886
MetLife
MET
$61B
| $16.7M | 0.02% |
326,852
-759,735
| -70% | -$36.7M |
|
887
Anika Therapeutics
ANIK
$199M
| $16.6M | 0.02% |
320,382
-87,912
| -22% | -$5.11M |
|
888
Gibraltar Industries
ROCK
$1.34B
| $16.6M | 0.02% |
329,345
+146,636
| +80% | +$7.36M |
|
|
BLUE
889
CALL
DELISTED
bluebird bio
BLUE
| $16.6M | 0.02% |
14,599
+1,884
| +15% | +$2.05M |
|
890
AdvanSix
ASIX
$567M
| $16.6M | 0.02% |
830,963
+15,815
| +2% | +$346K |
|
891
CALL
KLA
KLAC
$275B
| $16.6M | 0.02% |
930,000
+372,000
| +67% | +$6.24M |
|
892
Viavi Solutions
VIAV
$9.75B
| $16.5M | 0.02% |
1,101,260
+185,380
| +20% | +$2.77M |
|
|
VRTSP
893
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $16.5M | 0.02% |
162,645
| – | – |
|
|
AGN
894
CALL
DELISTED
Allergan plc
AGN
| $16.5M | 0.02% |
86,100
| – | – |
|
895
Fox Class A
FOXA
$23.2B
| $16.5M | 0.02% |
443,906
+44,697
| +11% | +$1.53M |
|
|
TWTR
896
CALL
DELISTED
Twitter, Inc.
TWTR
| $16.5M | 0.02% |
513,300
-434,400
| -46% | -$14.3M |
|
897
ServiceNow
NOW
$102B
| $16.4M | 0.02% |
290,425
-471,030
| -62% | -$24.8M |
|
|
BDXA
898
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $16.4M | 0.02% |
250,000
| – | – |
|
899
PUT
Philip Morris
PM
$301B
| $16.4M | 0.02% |
192,300
-46,000
| -19% | -$3.79M |
|
900
Applied Materials
AMAT
$426B
| $16.3M | 0.02% |
267,689
-1,668,665
| -86% | -$93.8M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.